Phase II trial of Immunotech's IPF-ITV-1 in patients with advanced HIV-AIDS

Trial Profile

Phase II trial of Immunotech's IPF-ITV-1 in patients with advanced HIV-AIDS

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Aug 2014

At a glance

  • Drugs ITV 1 (Primary)
  • Indications Acquired immunodeficiency syndrome; HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Aug 2014 Status changed from planning to completed.
    • 01 Mar 2013 Planned initiation date changed from 1 Mar 2013 to 1 May 2013, as reported in an Immunotech Laboratories media release.
    • 01 Mar 2013 Planned End Date changed from 1 Aug 2013 to 1 Oct 2013, as reported in an Immunotech Laboratories media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top